EAM
EW icon

Eagle Asset Management’s Edwards Lifesciences EW Stock Holding History

Eagle Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.01M Buy
30,282
+8,346
+38% +$606K 0.01% 461
2024
Q2 		$1.98M Buy
21,936
+11,052
+102% +$979K 0.01% 471
2024
Q1 		$1.03M Buy
10,884
+7,727
+245% +$649K 0.01% 502
2023
Q4 		$241K Buy
+3,157
New +$220K ﹤0.01% 541
2019
Q2 		– Sell
-1,602,246
Closed -$102M – 646
2019
Q1 		$102M Sell
1,602,246
-13,083
-0.8% -$747K 0.54% 47
2018
Q4 		$82.5M Buy
1,615,329
+168,429
+12% +$8.52M 0.52% 52
2018
Q3 		$84M Sell
1,446,900
-379,719
-21% -$18.6M 0.41% 77
2018
Q2 		$88.6M Buy
1,826,619
+213,456
+13% +$9.96M 0.48% 61
2018
Q1 		$75M Buy
1,613,163
+134,490
+9% +$5.84M 0.41% 80
2017
Q4 		$56.3M Buy
1,478,673
+139,224
+10% +$5.11M 0.31% 106
2017
Q3 		$49.1M Buy
1,339,449
+59,538
+5% +$2.27M 0.28% 127
2017
Q2 		$50.4M Buy
1,279,911
+449,286
+54% +$16.4M 0.3% 114
2017
Q1 		$26M Sell
830,625
-51,144
-6% -$1.6M 0.16% 188
2016
Q4 		$27.5M Sell
881,769
-16,641
-2% -$539K 0.18% 164
2016
Q3 		$36.1M Sell
898,410
-54,786
-6% -$2.06M 0.24% 131
2016
Q2 		$31.7M Sell
953,196
-16,437
-2% -$562K 0.22% 142
2016
Q1 		$28.5M Sell
969,633
-6,183
-0.6% -$171K 0.2% 159
2015
Q4 		$25.7M Buy
975,816
+60,126
+7% +$1.56M 0.17% 180
2015
Q3 		$21.7M Buy
915,690
+6,528
+0.7% +$158K 0.15% 201
2015
Q2 		$21.6M Buy
909,162
+61,908
+7% +$1.4M 0.12% 204
2015
Q1 		$20.1M Buy
847,254
+752,052
+790% +$16.9M 0.12% 220
2014
Q4 		$2.02M Sell
95,202
-75,924
-44% -$1.53M 0.01% 547
2014
Q3 		$2.91M Sell
171,126
-175,692
-51% -$2.77M 0.02% 526
2014
Q2 		$4.96M Sell
346,818
-52,872
-13% -$717K 0.03% 457
2014
Q1 		$4.94M Sell
399,690
-17,274
-4% -$199K 0.03% 482
2013
Q4 		$4.57M Sell
416,964
-290,256
-41% -$3.27M 0.03% 450
2013
Q3 		$8.11M Buy
707,220
+189,456
+37% +$2.22M 0.04% 401
2013
Q2 		$5.8M Buy
+517,764
New +$6.13M 0.04% 426

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Eagle Asset Management's EW Position: Q3 2024 in Review

Eagle Asset Management increased its Edwards Lifesciences (EW) stake by 38% in Q3 2024, buying an estimated $606K and bringing the position to 30,282 shares worth $2.01M. The position accounts for 0.01% of the portfolio, ranked #461.

Eagle Asset Management first reported a position in EW in Q2 2013 and has held it in 28 quarters since. The position peaked at $102M in Q1 2019. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Eagle Asset Management held 30,282 shares of Edwards Lifesciences worth $2.01M as of Q3 2024.
  • Eagle Asset Management bought 8,346 Edwards Lifesciences shares in Q3 2024, an estimated $606K.
  • Edwards Lifesciences made up 0.01% of Eagle Asset Management's portfolio in Q3 2024, its #461 holding.
  • Eagle Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 28 quarters since.
  • Eagle Asset Management's Edwards Lifesciences position peaked at $102M in Q1 2019.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.